Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacokinetics of PCBs.

H B Matthews, R L Dedrick

    Annual Review of Pharmacology and Toxicology
    |January 1, 1984
    PubMed
    Summary

    The pharmacokinetics of polychlorinated biphenyls (PCBs) vary significantly due to 209 congeners. A physiological pharmacokinetic model effectively predicts PCB disposition across species, aiding human risk assessment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fiber optic microfluorimetry for acute and chronic in-vivo animal studies.

    Journal of biomechanical engineering·2009
    Same author

    The effect of chlorine substitution on the disposition of polychlorinated biphenyls following dermal administration.

    Toxicology and applied pharmacology·2006
    Same author

    A physiologically based pharmacokinetic model of p,p'-dichlorodiphenylsulfone.

    Toxicology and applied pharmacology·2002
    Same author

    The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody.

    Journal of the American Academy of Dermatology·2001
    Same author

    Fluorescence recovery after photobleaching reveals that LPS rapidly transfers from CD14 to hsp70 and hsp90 on the cell membrane.

    Journal of cell science·2001
    Same author

    Finite element model of antibody penetration in a prevascular tumor nodule embedded in normal tissue.

    Journal of controlled release : official journal of the Controlled Release Society·2001

    Area of Science:

    • Environmental Chemistry
    • Toxicology
    • Pharmacokinetics

    Background:

    • Polychlorinated biphenyls (PCBs) exist as 209 distinct congeners.
    • PCBs are lipophilic, readily absorbed, and widely distributed but cleared at highly variable rates.
    • Clearance primarily depends on metabolism into more polar compounds, which varies by species and chlorination patterns.

    Purpose of the Study:

    • To explore the complex pharmacokinetics of PCBs.
    • To evaluate the utility of a physiological pharmacokinetic model for predicting PCB disposition.
    • To identify limitations in current models for human risk assessment.

    Main Methods:

    • Review of existing literature on PCB absorption, distribution, metabolism, and excretion (ADME).
    • Application of a physiological pharmacokinetic model to describe PCB disposition.
    • Extrapolation of animal model data to predict human PCB pharmacokinetics.

    Main Results:

    • PCB clearance rates differ significantly among congeners and species.
    • Metabolism is crucial for PCB clearance, with adjacent unsubstituted carbon atoms (3-4 positions) facilitating faster rates.
    • Congeners lacking these sites are metabolized slowly, leading to accumulation in adipose tissue.
    • A physiological pharmacokinetic model accurately described PCB disposition in rats and mice.
    • The model demonstrates how PCB body burden leads to tissue-specific exposures.

    Conclusions:

    • Physiological pharmacokinetic models offer a robust framework for extrapolating animal data to predict human PCB disposition.
    • Accurate human risk assessment requires better in vitro methods to estimate metabolic clearance rates of individual PCBs in humans.

    Related Experiment Videos